Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020

Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020

Guardado en:
Detalles Bibliográficos
Autores principales: Mariya Amin Qurieshi, S Muhammad Salim Khan, Inaamul Haq, Sabhiya Majid, Javid Ahmad, Taha Ayub, Ashfaq Ahmad Bhat, Anjum Bashir Fazili, Abdul Majeed Ganai, Yasmeen Jan, Rauf-ur-Rashid Kaul, Zahid Ali Khan, Muneer Ahmad Masoodi, Beenish Mushtaq, Fouzia Nazir, Muzamil Nazir, Malik Waseem Raja, Mahbooba Rasool, Anjum Asma, Shifana Ayoub, Munazza Aziz, Arif Akbar Bhat, Iqra Nisar Chowdri, Shaista Ismail, Misbah Ferooz Kawoosa, Mehvish Afzal Khan, Mosin Saleem Khan, Rafiya Kousar, Ab Aziz Lone, Shahroz Nabi, Mohammad Obaid, Tanzeela Bashir Qazi, Iram Sabah, Ishtiyaq Ahmad Sumji
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Medicine
R
Acceso en línea:https://doaj.org/article/43ec71e003794f80b9a123248d90b456
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/43ec71e003794f80b9a123248d90b456

Ejemplares similares